Molecular characterization and biomarker discovery in gastric cancer progression through transcriptome meta-analysis

Thiago Loreto Matos,Pedro Filho Noronha Souza,Maria Elisabete Amaral de Moraes,Silvia Helena Barem Rabenhorst,Felipe Pantoja Mesquita,Raquel Carvalho Montenegro
DOI: https://doi.org/10.1016/j.compbiomed.2024.109276
Abstract:Gastric cancer (GC) is a leading cause of cancer-related deaths globally. It is a multifactorial, molecularly heterogeneous disease whose carcinogenic patterns are not yet well established, requiring the development of new tools for better understanding and identifying gastric carcinogenesis. From this point of view, this study aims to compare transcriptome profiles from The Cancer Genome Atlas Stomach Adenocarcinoma (TCGA-STAD) and a human-merged dataset to identify potential biomarkers and therapeutic targets. Principal component analysis (PCA) revealed shared and distinct gene expression patterns between datasets. Differential expression analysis identified key genes with altered expression across non-malignant and malignant samples. Six genes, including SERPINE1 and CLDN9, were significantly associated with patient survival. The findings underscore the molecular diversity of GC and highlight novel biomarkers for early diagnosis and therapeutic strategies. Further validation in clinical specimens is necessary.
What problem does this paper attempt to address?